title: [Psoriasis and anxiety: marked improvement after anxiolytic therapy].
authors.forename: A
authors.initials: A
authors.lastname: Figueroa Quintana
authors.forename: A
authors.initials: A
authors.lastname: Díez Suárez
authors.forename: A
authors.initials: A
authors.lastname: España Alonso
authors.forename: C
authors.initials: C
authors.lastname: Soutullo Esperón
mesh_terms: D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001007:Anxiety / Q000150:complications / Q000188:drug therapy*; D002675:Child, Preschool; D003009:Clorazepate Dipotassium / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011565:Psoriasis / Q000188:drug therapy* / Q000209:etiology; D012074:Remission Induction
chemical_list: D014151:Anti-Anxiety Agents; D003009:Clorazepate Dipotassium